IL-21 enhances natural killer cell response to cetuximab-coated pancreatic tumor cells

PURPOSE: Alternative strategies to EGFR blockage by mAbs is necessary in order to improve the efficacy of therapy in patients with locally advanced or metastatic pancreatic cancer. One such strategy includes the use of NK cells to clear cetuximab-coated tumor cells, as need for novel therapeutic app...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Cancer Res
Egile Nagusiak: McMichael, Elizabeth L., Jaime-Ramirez, Alena Cristina, Guenterberg, Kristan D., Luedke, Eric, Atwal, Lakhvir S., Campbell, Amanda R., Hu, Zhiwei, Tatum, Armika S., Kondadasula, Sri Vidya, Mo, Xiaokui, Tridandapani, Susheela, Bloomston, Mark, Ellison, E. Christopher, Williams, Terence M., Bekaii-Saab, Tanios, Carson, William E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241232/
https://ncbi.nlm.nih.gov/pubmed/27435400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak